The disproportionate burdens of the mifepristone REMS

Contraception. 2021 Jul;104(1):16-19. doi: 10.1016/j.contraception.2021.05.001. Epub 2021 May 10.
No abstract available

Keywords: Abortion laws; FDA REMS; Health equity; Medication abortion; Mifepristone; Structural racism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortifacient Agents*
  • Abortifacient Agents, Steroidal*
  • Abortion, Induced*
  • Female
  • Humans
  • Mifepristone
  • Misoprostol*
  • Pregnancy

Substances

  • Abortifacient Agents
  • Abortifacient Agents, Steroidal
  • Misoprostol
  • Mifepristone